CDK18 and breast cancer: To validate the optimised CDK18 antibody conditions on human tissue sections, CDK18 immunohistochemical staining was assessed in commercial breast cancer tissue microarrays comprising of over 360 core biopsies of various cancer lineages, stage and grade, as well as normal healthy breast tissue and cancer adjacent controls (Supplementary Figure 1C).